Blood Cancer

• CLINICAL_TRIALS trial_result · 2026-04-02
  Clinical Trial Update: Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation [Phase 2]

  Open-label Phase II trial evaluating isatuximab for patients with refractory immune cytopenias after allogeneic hematopoietic cell transplan…

• CLINICAL_TRIALS trial_result · 2022-08-18
  Clinical Trial Update: Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL [Phase 1, Phase 2]

  Phase 1/2 trial of MT-3724 in relapsed or refractory diffuse large B-cell lymphoma and related B-cell hematologic malignancies; the study is…

• CLINICAL_TRIALS trial_result · 2017-10-03
  Clinical Trial Update: Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies [Phase 2]

  Phase 2 clinical trial update on allogeneic transplantation using total lymphoid irradiation and anti-thymocyte globulin in older patients w…

• CLINICAL_TRIALS trial_result · 2017-01-26
  Clinical Trial Update: Allogeneic Transplantation From Related Haploidentical Donors [Phase 2]

  A Phase 2 clinical trial evaluating allogeneic transplantation from related haploidentical donors for blood cancers and leukemia has complet…

• CLINICAL_TRIALS trial_result · 2013-02-07
  Clinical Trial Update: Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors [Phase 2]

  This update notes that a Phase 2 online survivorship workshop study sponsored by Stanford University has completed for cancer survivors, inc…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.